Tag - covid-19-vaccines

 
 

COVID 19 VACCINES

Japan Times
WORLD
Apr 17, 2021
Ontario sets up checkpoints and shuts construction as virus surges in Canada
The province is forcing nonessential construction sites to shut down and closing recreational facilities including golf courses, playgrounds and soccer fields.
Japan Times
ASIA PACIFIC
Apr 17, 2021
Vietnam calls for faster vaccine rollout before shots expire
Vietnam's health ministry called for the acceleration of its COVID-19 vaccine rollout on Friday as the expiry date of the Southeast Asian country's first batch of jabs supplied through the COVAX program fast approaches.
Japan Times
JAPAN
Apr 16, 2021
Tokyo Olympics chief commits to games as infections surge, amid fresh calls to cancel
Japan has exhibited 'poor performance' in containing transmission, along with limited testing capacity and a slow vaccination rollout, health experts wrote in the British Medical Journal
Japan Times
ASIA PACIFIC
Apr 15, 2021
How China fell behind after passing up a vaccine opportunity
In the early stages of the pandemic, China and other Asian nations failed to jump on mRNA tech, which has become the breakout star of the COVID-19 era.
Japan Times
BUSINESS
Apr 15, 2021
Even as vaccine rollouts accelerate, global air travel still stuck way behind 2019 levels
Measuring seats on offer shows that carriers currently have some 62 million seats per week, well short of the 2019 benchmark of 106 million.
Japan Times
JAPAN / Science & Health
Apr 15, 2021
FAQ: What to know about getting vaccinated against COVID-19 in Japan
Japan expanded inoculations to its elderly population on April 12, and will eventually roll out the vaccine out to the public. Here is what you need to know.
Japan Times
COMMENTARY / World
Apr 14, 2021
The FDA’s caution on the J&J vaccine is a costly mistake
The FDA acted after blood clots were observed in less than one in a million people who have received the J&J vaccine. COVID-19 has already killed 1,712 out of every million Americans.
Japan Times
WORLD / Science & Health
Apr 14, 2021
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
Japan Times
WORLD
Apr 13, 2021
U.S. calls for pause on Johnson & Johnson vaccine after clotting cases
The concerns about the shot mirror those about AstraZeneca's, which European regulators began investigating last month after some recipients developed blood clots.
Japan Times
JAPAN / ANALYSIS
Apr 12, 2021
Virus variants could propel fourth wave to new heights as Japan's cities clamp down
A significant increase in testing and genomic screening would better reveal the spread of virus variants, but experts question the country's ability and willingness to do so.
Japan Times
JAPAN
Apr 12, 2021
Japan’s slow vaccine rollout pushes back recovery time frame
The slow rollout means struggling businesses and fearful shoppers will have to hold out for longer as the economy's recovery is delayed by as much as two years compared with global peers.
Japan Times
ASIA PACIFIC
Apr 12, 2021
Asian nations scale back AstraZeneca rollout amid safety woes
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Japan Times
ASIA PACIFIC
Apr 12, 2021
China considering mixing COVID-19 vaccines to boost protection rate
The move comes after Beijing's top disease official said the country's available vaccines 'don't have very high rates of protection.'
Japan Times
WORLD / Science & Health
Apr 11, 2021
Astra vaccine unmasks EU split between West and desperate East
The former Eastern Bloc is home to almost a quarter of the EU's 440 million population and is struggling to tame the pandemic.
Japan Times
WORLD
Apr 11, 2021
South African variant can 'break through' Pfizer vaccine, Israeli study says
The study suggests the vaccine is less effective against the South African variant, compared with the original coronavirus and a variant first identified in Britain.
Japan Times
JAPAN
Apr 10, 2021
Japanese drug regulator to fast-track any modified vaccines to fight variants
Vaccines targeting new variants of the coronavirus won't require domestic clinical trials if the production process and handling of the shots are similar to those of the original.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?